Viewing StudyNCT06247722

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:04 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06247722
Status: RECRUITING
Last Update Posted: 2024-04-23
First Post: 2024-01-22
Brief Title: Real World Use of Tocilizumab Biosimilar studY
Sponsor: Fresenius Kabi SwissBioSim GmbH
Organization: Fresenius Kabi SwissBioSim GmbH
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Tyenne View
tocilizumab View
rheumatoid arthritis View
persistence View
real world use View
biosimilar View
biosimilar switch View